Today: 13 April 2026
Sprott Physical Silver Trust (PSLV) surges as silver hits record above $113 and traders brace for Fed week
26 January 2026
1 min read

Sprott Physical Silver Trust (PSLV) surges as silver hits record above $113 and traders brace for Fed week

New York, Jan 26, 2026, 13:25 EST — Regular session

  • PSLV surged about 13% by midday, tracking a sharp jump in silver prices.
  • Silver surged to a fresh peak, fueled by safe-haven demand and a burst of momentum buying.
  • Investors are zeroing in on the Fed’s decision due January 28 and the U.S. funding deadline looming on January 30.

Sprott Physical Silver Trust jumped Monday, boosted by a strong silver rally that pulled new money into metal-backed ETFs. PSLV gained $4.35, about 13.1%, reaching $37.57 in midday trading in New York.

The shift is notable, with silver reclaiming its place as a stress barometer. Investors treat it both as a safe haven and a high-beta bet on risk and inflation. But that setup can flip quickly, especially given a packed week ahead that might shake the dollar and real yields—two key drivers for metals.

Spot silver jumped to an all-time high of $113.61 an ounce after breaching the $100 mark late last week, fueled by robust momentum and a surge in retail buying, UBS analyst Giovanni Staunovo said. He warned, though, that prices at this level could start to dampen industrial demand.

Broader market nerves pushed demand higher. Silver surged more than 4% today and has climbed over 50% since January, fueled by a softer U.S. dollar and a move toward safe-haven assets, Reuters reported.

Other silver-focused funds matched the rally. iShares Silver Trust (SLV) surged about 13%, with abrdn Physical Silver Shares ETF (SIVR) logging a similar rise.

PSLV operates as a closed-end trust secured by physical silver bars, offering investors metal exposure without the need to manage the bullion themselves. Unlike typical ETFs, closed-end funds such as this often trade at prices that don’t always match the underlying asset value.

The trust’s latest update showed a net asset value of $35.30 per unit, with holdings totaling 217.7 million ounces of silver. At that time, the fund was trading below its NAV—a sign that in volatile markets, discounts and premiums can widen unexpectedly.

Not everyone is sold on silver’s surge. Some analysts warn the rapid climb looks like a bubble and could spark profit-taking if the momentum slips.

The Federal Reserve takes center stage next. The FOMC meets January 27-28, announcing its policy decision at 2 p.m. ET Wednesday. Chair Jerome Powell is scheduled to speak 30 minutes after that.

The meeting is expected to keep rates unchanged, but mounting political tensions around the Fed are casting a shadow over the market, muddying the prospects for the dollar and safe-haven assets, Reuters reports.

Traders remain focused on Washington’s funding impasse, with current funding set to expire on Jan. 30. The deadlock has sparked renewed concerns over a potential government shutdown—a looming risk that could unsettle metals markets if political tensions escalate.

Stock Market Today

  • Life Science Sector Seeks $693 Million in US IPOs with Kailera and Alamar
    April 13, 2026, 1:40 PM EDT. Two U.S. health-care firms, Kailera Therapeutics and Alamar Biosciences, are launching initial public offerings (IPOs) aiming to raise up to $693 million combined. Kailera, specializing in obesity biotech, targets $533 million to advance its drug pipeline, including a promising GLP-1 obesity treatment in Phase 3 trials. Alamar, a medical device maker for disease diagnosis, plans to raise $159.4 million to boost research and manufacturing. The IPOs are part of a broader $2.37 billion raised by U.S. health-care companies in 2026, consistent with 2025 levels. Both offerings expect to price on April 16, with backing from major investors such as Bain Capital and Qiming Venture Partners.

Latest article

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

Marvell Stock Hits Record High After Nvidia’s $2 Billion Move and Amazon AI Chip Push

13 April 2026
Marvell Technology shares rose 2.1% to $131.22 Monday, hitting a record after Nvidia’s $2 billion investment and renewed optimism over Amazon’s AI chip business. The stock earlier touched $135.18. Barclays upgraded Marvell and raised its price target to $150, citing surging demand for optical products in AI data centers. Nvidia and Marvell plan to link custom chips for Nvidia’s NVLink Fusion platform.
Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

Intel Stock Rally Extends as $100 Billion April Run Draws Fresh Wall Street Bets

13 April 2026
Intel shares climbed $2.09 to $64.47 by late morning Monday, extending a rally that has added over $100 billion in value across eight sessions. The surge follows a raised price target, new deals with Google and Elon Musk’s Terafab, and Intel’s $14.2 billion buyback of Apollo’s Fab 34 stake. The stock is up 69% in 2026 after an 84% gain last year. Intel reports first-quarter results April 23.
Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

13 April 2026
Nebius Group shares climbed 7.4% to $155.74 by midday Monday after Bank of America raised its price target to $175, despite Freedom Capital Markets downgrading the stock to Hold. The Amsterdam-based AI infrastructure firm recently secured a five-year deal with Meta worth up to $27 billion and holds over $40 billion in supply contracts with Microsoft and Meta. Nebius also closed $4.34 billion in convertible debt and sold $2 billion in warrants to Nvidia.
Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

13 April 2026
Salesforce faced renewed attention after reports of stake reductions by Choreo LLC and Sumitomo Mitsui Trust Group, based on SEC filings from January that reflected year-end positions. Choreo held 27,733 shares and Sumitomo Mitsui 2,478,864 shares as of December 31. The reported cuts amounted to about 35% and 8.6%, respectively. Salesforce shares rose 3.4% Monday, while broader software stocks remain down for the year.
Coinbase stock slips today as SEC drops Gemini case and Fed week looms
Previous Story

Coinbase stock slips today as SEC drops Gemini case and Fed week looms

DigitalOcean stock jumps nearly 15% as AI-inference push keeps buyers in control
Next Story

DigitalOcean stock jumps nearly 15% as AI-inference push keeps buyers in control

Go toTop